Bronchial basal cells

BIOLOGICAL5 trials

Sponsors

Regend Therapeutics, First Affiliated Hospital of Shantou University Medical College, Ruijin Hospital

Conditions

BronchiectasisCOPDChronic Obstructive Pulmonary DiseaseChronic Respiratory Disease

Early Phase 1

Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF

Regend TherapeuticsChronic Respiratory Disease

Start: 2017-04-05End: 2021-10-04Target: 30Updated: 2019-09-18

Treatment of COPD by Autologous Transplantation of Bronchial Basal Cells

First Affiliated Hospital of Shantou University Medical CollegeChronic Obstructive Pulmonary Disease

Start: 2017-04-01End: 2022-06-30Target: 20Updated: 2017-05-17

Phase 1

Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis

Regend TherapeuticsBronchiectasis

Start: 2016-03-31End: 2020-06-30Target: 20Updated: 2020-03-18

Autologous Bronchial Basal Cell Transplantation for Treatment of COPD

CompletedNCT03188627

Regend TherapeuticsChronic Obstructive Pulmonary Disease

Start: 2018-06-12End: 2019-12-26Updated: 2023-03-24

Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD

Ruijin HospitalCOPD

Start: 2018-11-30End: 2021-03-31Target: 20Updated: 2018-11-06